5033 — Nulab Income Statement
0.000.00%
- ¥7bn
- ¥4bn
- ¥4bn
- 88
- 48
- 73
- 83
Annual income statement for Nulab, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,586 | 1,939 | 2,328 | 2,706 | 3,663 |
Cost of Revenue | |||||
Gross Profit | 784 | 1,090 | 1,416 | 1,734 | 2,638 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,626 | 1,958 | 2,161 | 2,611 | 3,338 |
Operating Profit | -39.8 | -19.6 | 167 | 94.9 | 325 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -48.4 | -21.4 | 164 | 86.3 | 323 |
Provision for Income Taxes | |||||
Net Income After Taxes | -52.9 | -25.5 | 198 | 88.4 | 308 |
Net Income Before Extraordinary Items | |||||
Net Income | -52.9 | -25.5 | 198 | 88.4 | 308 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -52.9 | -25.5 | 198 | 88.4 | 308 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -8.2 | -2.66 | 30.7 | 14.6 | 48.2 |
Dividends per Share |